Canada markets closed

Sanofi (SNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
45.30-0.21 (-0.46%)
At close: 4:00PM EDT

45.10 -0.20 (-0.44%)
After hours: 4:05PM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close45.51
Open45.39
Bid45.23 x 800
Ask45.98 x 900
Day's Range44.76 - 45.54
52 Week Range37.62 - 55.00
Volume1,466,805
Avg. Volume1,044,129
Market Cap114.932B
Beta (5Y Monthly)0.37
PE Ratio (TTM)23.35
EPS (TTM)1.94
Earnings DateN/A
Forward Dividend & Yield1.70 (3.73%)
Ex-Dividend DateApr. 30, 2020
1y Target Est61.38
  • Sanofi (SNY) Q3 2020 Earnings Call Transcript
    Motley Fool

    Sanofi (SNY) Q3 2020 Earnings Call Transcript

    SNY earnings call for the period ending September 30, 2020.

  • Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study
    Zacks

    Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study

    Eli Lilly (LLY), Merck (MRK), Pfizer (PFE), Novartis (NVS) and others release Q3 results

  • Activists urge 'Big Pharma' to be transparent on COVID-19 vaccine costs
    Reuters

    Activists urge 'Big Pharma' to be transparent on COVID-19 vaccine costs

    Activists called on pharmaceutical companies on Thursday to be transparent about the costs and terms of providing COVID-19 vaccines, saying they must be available and affordable for all. French drugmaker Sanofi <SASY.PA> and Britain's GlaxoSmithKline <GSK.L> said on Wednesday they would supply 200 million doses of their COVID-19 candidate vaccine to the global COVAX vaccine facility backed by the World Health Organization (WHO) and the GAVI vaccine alliance. Medecins Sans Frontieres (Doctors Without Borders) demanded the two companies provide details around price, supply and distribution of any vaccine proven safe and effective.